Quasar Medical Strengthens Global CDMO Platform with Acquisition of Nordson Medical's Galway and Tecate Facilities

Rhea-AI Summary

Quasar Medical has completed the acquisition of Nordson Corporation's (NASDAQ: NDSN) design & development contract manufacturing facilities in Galway, Ireland, and Tecate, Mexico. This strategic move transforms Quasar into a fully integrated Contract Development and Manufacturing Organization (CDMO), expanding its workforce by nearly 200 employees.

The acquisition adds two FDA-registered, ISO 13485-certified facilities in key MedTech regions. The Galway facility will serve as an innovation hub for design & development of medical devices, while the Tecate location will provide cost-effective, high-volume manufacturing capabilities. The expansion strengthens Quasar's ability to offer end-to-end solutions for complex interventional devices, from concept to commercialization.

Positive

• Expansion of global presence with two FDA-registered, ISO 13485-certified facilities in strategic MedTech regions
• Addition of 200 skilled employees including expert development engineers and technicians
• Enhanced end-to-end capabilities from product development to high-volume manufacturing
• Increased cleanroom footprint and technical expertise in medical device manufacturing
• Strategic positioning in both European and North American markets improving customer proximity

Negative

• Integration challenges with merging operations and workforce from two different facilities
• Potential transition risks for existing customers and suppliers
• Increased operational complexity managing facilities across multiple regions

This milestone enhances Quasar's global CDMO platform, broadening end-to-end capabilities and providing increased value for medical device OEMs and innovators.

GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Quasar Medical, a global leader in manufacturing interventional and minimally invasive medical devices, today announced the completion of its acquisition of Nordson Corporation's (Nasdaq: NDSN) design & development contract manufacturing businesses in Galway, Ireland, and Tecate, Mexico.

Quasar's evolution into a fully integrated Contract Development and Manufacturing Organization (CDMO) marks a transformative step, offering customers concept-to-commercialization solutions worldwide. The company is expanding its workforce by nearly 200 employees, including expert development engineers and technicians, creating new opportunities for advancement.

"This strategic acquisition marks an exciting new chapter for Quasar and the customers we serve," said Alex Wallstein, CEO of Quasar Medical. "By combining our manufacturing excellence with the world-class design, development, and assembly expertise of the Galway and Tecate teams, we are expanding our global reach, moving closer to our customers and creating a truly global CDMO platform. Together, we will partner with customers and suppliers earlier in the product lifecycle, delivering innovation, scalability, and speed to market at every stage."

With this acquisition, Quasar strengthens its global presence with two FDA-registered, ISO 13485-certified facilities situated in key MedTech regions—Europe and North America—improving customer proximity and access. Galway, Ireland, now serves as an innovation hub for design & development for extrusions, braiding, balloons, and complex catheters, providing advanced support in product design, prototyping, and clinical innovation. Tecate, Mexico, adds cost-effective, high-volume manufacturing capabilities, facilitating a smoother transition from development to commercialization.

"This is a pivotal milestone that positions Quasar as a strategic partner to our customers — not just a manufacturer," said Aviel Bohnik, COO of Quasar Medical. "With the addition of Galway and Tecate, we now offer a truly differentiated platform that combines upstream innovation, downstream scalability, and our unsurpassed ramp-up capabilities—accelerating time to market for our customers. These new sites strengthen our ability to deliver high-value solutions through vertical integration, customer collaboration, and operational excellence across key regions."

A Stronger Future for Customers

By expanding its regional reach and integrating Nordson Medical's design, development, and contract manufacturing capabilities into its global platform, Quasar can now provide a seamless, end-to-end solution for complex interventional devices, including:

• Advanced product development and rapid prototyping in Galway
• Design-for-manufacturing expertise, balloon catheter and shaft development, and comprehensive testing capabilities
• Scalable manufacturing and assembly in Tecate, including molding, coating, packaging, and automated processes

The acquisition also greatly expands Quasar's cleanroom footprint, enhances deep technical expertise in extrusions, balloons, balloon catheters, braided shafts, and delivery systems, and creates more room for growth at both sites. Customers will benefit from regional access in North America and Europe, faster development, enhanced quality control, and more cost-effective manufacturing.

Quasar will collaborate closely with Nordson to ensure a seamless transition for employees, customers, and suppliers.

About

Quasar Medical is a global Contract Development and Manufacturing Organization (CDMO) delivering end-to-end solutions for interventional and minimally invasive medical devices. With 11 global facilities and over 4,300 employees across Asia, North America, and Europe, Quasar specializes in catheter systems, balloon technologies, micro-EM sensors, and complex assemblies, delivering cost-effective scalability and unmatched speed to market. Headquartered in Singapore, the company provides fully integrated device solutions spanning design, prototyping, and scalable manufacturing. Quasar operates under ISO 13485:2016 and cGMP standards, serving leading medical device OEMs and innovators worldwide. For more information, visit www.quasarmedical.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/quasar-medical-strengthens-global-cdmo-platform-with-acquisition-of-nordson-medicals-galway-and-tecate-facilities-302543969.html

SOURCE Quasar Medical

FAQ

What facilities did Quasar Medical acquire from Nordson Corporation (NASDAQ: NDSN)?

Quasar Medical acquired Nordson's design & development contract manufacturing facilities in Galway, Ireland and Tecate, Mexico, both FDA-registered and ISO 13485-certified.

How many employees will be added to Quasar Medical through this acquisition?

The acquisition will add nearly 200 employees to Quasar Medical, including expert development engineers and technicians.

What manufacturing capabilities does the Galway facility bring to Quasar Medical?

The Galway facility serves as an innovation hub for design & development of extrusions, braiding, balloons, and complex catheters, offering advanced support in product design, prototyping, and clinical innovation.

What is the strategic importance of the Tecate, Mexico facility?

The Tecate facility provides cost-effective, high-volume manufacturing capabilities and facilitates smoother transition from development to commercialization of medical devices.

How will this acquisition benefit Quasar Medical's customers?

Customers will benefit from regional access in North America and Europe, faster development times, enhanced quality control, more cost-effective manufacturing, and end-to-end solutions for complex interventional devices.